Ref.: BL-RE-143957Manufacturer ref.: EMTNFSF11X10 10 x 96 tests
€4,815.00 excl. VAT
This gene codes a member of the tumour necrosis factor cytokines (TNF), which is a ligand for benzoprotein and plays a key role in the differentiation and activation of osteoclasts. It's been shown that...
Accession number
O35235
Dose range
2.74 to 2.000 pg/ml
Sensitivity of the dosage
4 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
This gene codes a member of the tumour necrosis factor cytokines (TNF), which is a ligand for benzoprotein and plays a key role in the differentiation and activation of osteoclasts. It's been shown that...
This gene codes a member of the tumour necrosis factor cytokines (TNF), which is a ligand for benzoprotein and plays a key role in the differentiation and activation of osteoclasts. This protein has been shown to be a survival factor of the dentritic cells and is involved in regulating T-cell-dependent immune response. T cell activation induces expression of this gene and results in increased osteoclastogenesis and bone loss. This protein has been shown to activate AKT/PKB antiapoptotic kinase via a signaling complex involving SRC kinase and the tumour necrosis factor receptor (TRAF) 6 factor, indicating that this protein may play a role in the regulation of cell l-apoptosis. Targeted disturbance of the mouse-related gene resulted in severe osteopretrose and lack of osteoclastics. Deficiencies in early differentiation of T and B lymphocytes were observed in mice and were not successful in forming lobulo-alveolar breast structures during pregnancy. Two alternative-spinning transcription variants were found.
Sensitivity
Sensitivity of the dosage: 4 pg/ml.
Measurement range
Dose range: 2.74 to 2.000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Coefficient of intradose variation < 10%, interdose < 12%.